Extract from the Register of European Patents

EP About this file: EP3393510

EP3393510 - ZIKA VIRUS VACCINE [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  20.01.2023
Database last updated on 31.03.2026
FormerGrant of patent is intended
Status updated on  29.08.2022
FormerExamination is in progress
Status updated on  12.02.2020
FormerRequest for examination was made
Status updated on  28.09.2018
FormerThe international publication has been made
Status updated on  05.07.2017
Formerunknown
Status updated on  27.01.2017
Most recent event   Tooltip20.02.2026New entry: Despatch of communication that the patent will be maintained as amended 
Applicant(s)For all designated states
Valneva Austria GmbH
Campus Vienna Biocenter 3
1030 Vienna / AT
[2018/44]
Inventor(s)01 / BARBERO CALZADO, Jana
Valneva Austria GmbH
Mittersteig 20/21
1050 Vienna / AT
02 / NEBENFÜHR, Mario
Valneva Austria GmbH
Grimmelshausengasse 12/27
1030 Vienna / AT
03 / SCHLEGL, Robert
Valneva Austria GmbH
Rosenthal 63
2500 Siegenfeld / AT
04 / WEBER, Michael
Valneva Austria GmbH
Rechte Wienzeile 249/15
1120 Vienna / AT
05 / WRUSS, Jürgen
Valneva Austria GmbH
Dampfgasse 25/27-29
1100 Vienna / AT
 [2018/44]
Representative(s)Script Intellectual Property LLP
Suite J, Anchor House
School Close
Chandlers Ford
Eastleigh, Hampshire SO53 4DY / GB
[N/P]
Former [2023/08]Script IP Limited
Turnpike House
18 Bridge Street
Frome Somerset BA11 1BB / GB
Former [2018/44]Dempster, Robert Charles
Script IP Limited
Turnpike House
18 Bridge Street
Frome
Somerset BA11 1BB / GB
Application number, filing date16828746.423.12.2016
[2018/44]
WO2016EP82664
Priority number, dateEP2015020258523.12.2015         Original published format: EP 15202585
EP2016016106818.03.2016         Original published format: EP 16161068
EP2016017602523.06.2016         Original published format: EP 16176025
EP2016017604923.06.2016         Original published format: EP 16176049
EP2016018284504.08.2016         Original published format: EP 16182845
[2018/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017109225
Date:29.06.2017
Language:EN
[2017/26]
Type: A1 Application with search report 
No.:EP3393510
Date:31.10.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 29.06.2017 takes the place of the publication of the European patent application.
[2018/44]
Type: B1 Patent specification 
No.:EP3393510
Date:22.02.2023
Language:EN
[2023/08]
Search report(s)International search report - published on:EP29.06.2017
ClassificationIPC:A61K39/12, C07K14/005
[2018/44]
CPC:
A61K39/12 (EP,CN,KR,US); A61K39/39 (CN,KR,US); A61P31/14 (EP,CN,US);
C07K14/18 (US); C07K14/1825 (US); C12N7/00 (US);
C12N7/02 (US); C12N7/06 (US); A61K2039/5252 (EP,KR,US);
A61K2039/5254 (US); A61K2039/5258 (US); A61K2039/55505 (CN,KR,US);
A61K2039/55516 (CN,KR); A61K2039/55561 (CN,KR); C12N2770/24134 (EP,CN,KR,US);
C12N2770/24151 (EP,US); C12N2770/24163 (EP,CN,KR,US); Y02A50/30 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/44]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:ZIKAVIRUS-IMPFSTOFF[2022/34]
English:ZIKA VIRUS VACCINE[2018/44]
French:VACCIN CONTRE LE VIRUS ZIKA[2018/44]
Former [2018/44]IMPFSTOFF GEGEN DEN ZIKA-VIRUS
Entry into regional phase20.07.2018National basic fee paid 
20.07.2018Designation fee(s) paid 
20.07.2018Examination fee paid 
Examination procedure20.07.2018Examination requested  [2018/44]
20.07.2018Date on which the examining division has become responsible
18.02.2019Amendment by applicant (claims and/or description)
17.02.2020Despatch of a communication from the examining division (Time limit: M06)
20.08.2020Reply to a communication from the examining division
18.02.2021Despatch of a communication from the examining division (Time limit: M04)
22.06.2021Reply to a communication from the examining division
13.10.2021Observations by third parties
03.02.2022Despatch of a communication from the examining division (Time limit: M04)
04.05.2022Reply to a communication from the examining division
30.08.2022Communication of intention to grant the patent
09.01.2023Fee for grant paid
09.01.2023Fee for publishing/printing paid
09.01.2023Receipt of the translation of the claim(s)
Divisional application(s)EP23152481.0  / EP4218807
Opposition(s)Opponent(s)01  21.11.2023  22.11.2023  ADMISSIBLE
Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
Opponent's representative
Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
 [2023/52]
06.12.2023Invitation to proprietor to file observations on the notice of opposition
28.03.2024Reply of patent proprietor to notice(s) of opposition
23.09.2025Cancellation of oral proceeding that was planned for 15.10.2025
15.10.2025Date of oral proceedings
14.11.2025Despatch of interlocutory decision in opposition
14.11.2025Legal effect of interlocutory decision in opposition
20.02.2026Despatch of communication that the patent will be maintained as amended
Fees paidRenewal fee
20.07.2018Renewal fee patent year 03
23.12.2019Renewal fee patent year 04
24.12.2020Renewal fee patent year 05
24.12.2021Renewal fee patent year 06
29.12.2022Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Rights in Rem or Legal Means of ExecutionID:01
For:AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Date:16.03.2020
[2020/19]
Lapses during opposition  TooltipMC22.02.2023
RS22.02.2023
SM22.02.2023
IS22.06.2023
[2024/40]
Former [2023/46]RS22.02.2023
SM22.02.2023
IS22.06.2023
Former [2023/39]RS22.02.2023
IS22.06.2023
Former [2023/34]RS22.02.2023
Cited inInternational search[YD] US8765148  (WIZEL BENJAMIN et al.) [YD] 13,14 * column 1 *
 [XPI] WO2016145149  (THE US SECRETARY OF THE ARMY ON BEHALF OF THE WALTER REED ARMY INST OF RES et al.) [XP] 1,2,5-12,15 * page 5, lines 8-17 * * paragraphs [0037] - [0040] * * paragraph [0048] * * claims 1-19 *[I] 3,4
 [E] WO2017009873  (BHARAT BIOTECH INT LTD et al.) [E] 1-12,15 * examples 1, 2,3,5-7 *
 [AD] US6309650  (KIM HYUN SU et al.) [AD] 1-17 * examples 3-5; tables 5,6 *
 [XP] CN105749268  (SINOVAC RES & DEV CO LTD et al.) [XP] 1-8,10-12,15 * the whole document *
 [Y]   B. D. COX ET AL: "Predicting Zika virus structural biology: Challenges and opportunities for intervention", ANTIVIRAL CHEMISTRY & CHEMOTHERAPY., vol. 24, no. 3-4, 1 August 2015 (2015-08-01), GB, pages 118 - 126, XP055328128, ISSN: 0956-3202, DOI: 10.1177/2040206616653873 [Y] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.1177/2040206616653873
 [YD]   SRIVASTAVA A K ET AL: "A purified inactivated Japanese encephalitis virus vaccine made in vero cells", VACCINE, vol. 19, no. 31, 14 August 2001 (2001-08-14), pages 4557 - 4565, XP027321987, ISSN: 0264-410X, [retrieved on 20010814] [YD] 1-17 * the whole document *
 [XDPI]   RAFAEL A. LAROCCA ET AL: "Vaccine protection against Zika virus from Brazil", NATURE, vol. 536, no. 7617, 28 June 2016 (2016-06-28), United Kingdom, pages 474 - 478, XP055314483, ISSN: 0028-0836, DOI: 10.1038/nature18952 [XDP] 1-12,16,17 * abstract * * page 475, column r, paragraph l - page 476, column l, paragraph 1 * [I] 15

DOI:   http://dx.doi.org/10.1038/nature18952
OppositionUS8765148
 WO2016145149
 WO2017009873
 CN105749268
 US11219681
 WO2013083726
 WO2004084938
 WO2017009873
   B. D. COX, R. A. STANTON, R. F. SCHINAZI: "Predicting Zika virus structural biology: Challenges and opportunities for intervention", ANTIVIRAL CHEMISTRY & CHEMOTHERAPY., INTERNATIONAL MEDICAL PRESS, GB, vol. 24, no. 3-4, 1 August 2015 (2015-08-01), GB , pages 118 - 126, XP055328128, ISSN: 0956-3202, DOI: 10.1177/2040206616653873

DOI:   http://dx.doi.org/10.1177/2040206616653873
   SRIVASTAVA, A.K. PUTNAK, J.R. LEE, S.H. HONG, S.P. MOON, S.B. BARVIR, D.A. ZHAO, B. OLSON, R.A. KIM, S.-O. YOO, : "A purified inactivated Japanese encephalitis virus vaccine made in vero cells", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 19, no. 31, 14 August 2001 (2001-08-14), AMSTERDAM, NL , pages 4557 - 4565, XP004296120, ISSN: 0264-410X, DOI: 10.1016/S0264-410X(01)00208-0

DOI:   http://dx.doi.org/10.1016/S0264-410X(01)00208-0
   RAFAEL A. LAROCCA, PETER ABBINK, JEAN PIERRE S. PERON, PAOLO M. DE A. ZANOTTO, M. JUSTIN IAMPIETRO, ALEXANDER BADAMCHI-ZADEH, MICH: "Vaccine protection against Zika virus from Brazil", NATURE, vol. 536, no. 7617, 1 August 2016 (2016-08-01), pages 474 - 478, XP055550329, DOI: 10.1038/nature18952

DOI:   http://dx.doi.org/10.1038/nature18952
   P. ABBINK, R. A. LAROCCA, R. A. DE LA BARRERA, C. A. BRICAULT, E. T. MOSELEY, M. BOYD, M. KIRILOVA, Z. LI, D. NGANGA, O. NANAYAKKA: "Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 353, no. 6304, 9 September 2016 (2016-09-09), US , pages 1129 - 1132, XP055314484, ISSN: 0036-8075, DOI: 10.1126/science.aah6157

DOI:   http://dx.doi.org/10.1126/science.aah6157
   ABBINK PETER, LAROCCA RAFAEL A., DE LA BARRERA RAFAEL A., BRICAULT CHRISTINE A., MOSELEY EDWARD T., BOYD MICHAEL, KIRILOVA MARINEL: "Supplementary Materials for Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 353, no. 6304, 9 September 2016 (2016-09-09), US , pages 1 - 20, XP093145214, ISSN: 0036-8075, DOI: 10.1126/science.aah6157

DOI:   http://dx.doi.org/10.1126/science.aah6157
   J. COHEN: "The race for a Zika vaccine is on", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 351, no. 6273, 5 February 2016 (2016-02-05), US , pages 543 - 544, XP055360676, ISSN: 0036-8075, DOI: 10.1126/science.351.6273.543

DOI:   http://dx.doi.org/10.1126/science.351.6273.543
   ROBERT PUTNAK, DAVID A. BARVIR, JEANNE M. BURROUS, DORIA R. DUBOIS, VALERIE M. D'ANDREA, CHARLES H. HOKE, JERALD C. SADOFF, KENNET: "Development of a Purified, Inactivated, Dengue-2 Virus Vaccine Prototype in Vero Cells: Immunogenicity and Protection in Mice and Rhesus Monkeys ", JOURNAL OF INFECTIOUS DISEASES, UNIVERSITY OF CHICAGO PRESS, US, vol. 174., no. 06., 1 December 1996 (1996-12-01), US , pages 1176 - 1184, XP000952637, ISSN: 0022-1899, DOI: 10.1093/infdis/174.6.1176

DOI:   http://dx.doi.org/10.1093/infdis/174.6.1176
   C. BARONTI, G. PIORKOWSKI, R. N. CHARREL, L. BOUBIS, I. LEPARC-GOFFART, X. DE LAMBALLERIE: "Complete Coding Sequence of Zika Virus from a French Polynesia Outbreak in 2013", GENOME ANNOUNCEMENTS, vol. 2, no. 3, 5 June 2014 (2014-06-05), pages e00500 - e00500-14, XP055313805, DOI: 10.1128/genomeA.00500-14

DOI:   http://dx.doi.org/10.1128/genomeA.00500-14
   MUSSO DIDIER: "Zika Virus Transmission from French Polynesia to Brazil", EMERGING INFECTIOUS DISEASES, EID, ATLANTA, GA, US, vol. 21, no. 10, 1 October 2015 (2015-10-01), US , pages 1887 - 1887, XP093145227, ISSN: 1080-6040, DOI: 10.3201/eid2110.151125

DOI:   http://dx.doi.org/10.3201/eid2110.151125
   ENFISSI ANTOINE; CODRINGTON JOHN; ROOSBLAD JIMMY; KAZANJI MIRDAD; ROUSSET DOMINIQUE: "Zika virus genome from the Americas", THE LANCET, ELSEVIER, AMSTERDAM, NL, vol. 387, no. 10015, 8 January 2016 (2016-01-08), AMSTERDAM, NL , pages 227 - 228, XP029389195, ISSN: 0140-6736, DOI: 10.1016/S0140-6736(16)00003-9

DOI:   http://dx.doi.org/10.1016/S0140-6736(16)00003-9
   ROBERT SCHLEGL, MICHAEL WEBER, JRGEN WRUSS, DONALD LOW, KIRSTEN QUEEN, SHAUN STILWELL, ERIK B. LINDBLAD, MICHAEL MHLEN: "Influence of elemental impurities in aluminum hydroxide adjuvant on the stability of inactivated Japanese Encephalitis vaccine, IXIARO", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 33, no. 44, 1 November 2015 (2015-11-01), AMSTERDAM, NL , pages 5989 - 5996, XP055315021, ISSN: 0264-410X, DOI: 10.1016/j.vaccine.2015.05.103

DOI:   http://dx.doi.org/10.1016/j.vaccine.2015.05.103
   "Vaccine Analysis: Strategies, Principles, and Control", 1 January 2015, SPRINGER BERLIN HEIDELBERG, Berlin, Heidelberg, ISBN: 978-3-662-45024-6, article SANDERS BARBARA, KOLDIJK MARTIN, SCHUITEMAKER HANNEKE: "2.1 Introduction to Vaccines Based on Inactivated Viruses", pages: 45 - 49, XP093145240, DOI: 10.1007/978-3-662-45024-6_2

DOI:   http://dx.doi.org/10.1007/978-3-662-45024-6_2
   "Manual of Aquatic Viral Ecology", 1 January 2010, AMERICAN SOCIETY OF LIMNOLOGY AND OCEANOGRAPHY , ISBN: 978-0-9845591-0-7, article LAWRENCE JANICE E., STEWARD GRIEG F.: "Purification of viruses by centrifugation", pages: 166 - 181, XP093145249, DOI: 10.4319/mave.2010.978-0-9845591-0-7.166

DOI:   http://dx.doi.org/10.4319/mave.2010.978-0-9845591-0-7.166
   HOMBACH, J. ; SOLOMON, T. ; KURANE, I. ; JACOBSON, J. ; WOOD, D.: "Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 23, no. 45, 1 November 2005 (2005-11-01), AMSTERDAM, NL , pages 5205 - 5211, XP027651994, ISSN: 0264-410X
   ZHANG XIANWEN, XIE XUPING, ZOU JING, XIA HONGJIE, SHAN CHAO, CHEN XINWEN, SHI PEI-YONG: "Genetic and biochemical characterizations of Zika virus NS2A protein", EMERGING MICROBES & INFECTIONS, NPG, vol. 8, no. 1, 1 January 2019 (2019-01-01), pages 585 - 602, XP093145254, ISSN: 2222-1751, DOI: 10.1080/22221751.2019.1598291

DOI:   http://dx.doi.org/10.1080/22221751.2019.1598291
   PETERSEN LYLE R., JAMIESON DENISE J., POWERS ANN M., HONEIN MARGARET A.: "Zika Virus", THE NEW ENGLAND JOURNAL OF MEDICINE, MASSACHUSETTS MEDICAL SOCIETY, US, vol. 374, no. 16, 21 April 2016 (2016-04-21), US , pages 1552 - 1563, XP093145258, ISSN: 0028-4793, DOI: 10.1056/NEJMra1602113

DOI:   http://dx.doi.org/10.1056/NEJMra1602113
   N. N.: "VALNEVA AUSTRIA GMBH IXIARO HIGHLIGHTS OF PRESCRIBING INFORMATION", 1 September 2018 (2018-09-01), XP055767985, [retrieved on 20210122]
   DATABASE Nucleotide NCBI; ANONYMOUS : "Zika virus strain H/PF/2013 polyprotein gene, complete cds", XP093145292
   ANONYMOUS: "Zika Virus, Microcephaly and Guillain-Barr Syndrome Situation Report", WHO SITUATION REPORT, WHO, 17 March 2016 (2016-03-17), pages 1 - 13, XP093145300, Retrieved from the Internet [retrieved on 20240325]
   ANONYMOUS: "Current Zika Product Pipeline", WORLD HEALTH ORGANIZATION, XP055276663, Retrieved from the Internet [retrieved on 20160531]
   PELLERIN CHERYL : "Walter Reed Scientists Test Zika Vaccine Candidate", DOD NEWS, 9 June 2016 (2016-06-09), pages 1 - 6, XP093195461, Retrieved from the Internet [retrieved on 20240815]
   ROBERT S. LANCIOTTI, AMY J. LAMBERT, MARK HOLODNIY, SONIA SAAVEDRA, LETICIA DEL CARMEN CASTILLO SIGNOR: "Phylogeny of Zika Virus in Western Hemisphere, 2015", EMERGING INFECTIOUS DISEASES, vol. 22, no. 5, 1 May 2016 (2016-05-01), pages 933 - 935, XP055684161, DOI: 10.3201/eid2205.160065

DOI:   http://dx.doi.org/10.3201/eid2205.160065
   J. COHEN: "The race for a Zika vaccine is on", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 351, no. 6273, 5 February 2016 (2016-02-05), US , pages 543 - 544, XP055360676, ISSN: 0036-8075, DOI: 10.1126/science.351.6273.543

DOI:   http://dx.doi.org/10.1126/science.351.6273.543
   PELLERIN CHERYL : "Walter Reed Scientists Test Zika Vaccine Candidate", DOD NEWS, 9 June 2016 (2016-06-09), pages 1 - 6, XP093195461, Retrieved from the Internet [retrieved on 20240815]
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.